Publications & Works

Publication Network
Articles 65
All (65)
SCI-E, SSCI, AHCI (50)
SCI-E, SSCI, AHCI, ESCI (58)
ESCI (8)
Scopus (60)
TRDizin (19)
Other Publications (1)

1. Clinical and Laboratory Characteristics of Patients with Neurosarcoidosis Nörosarkoidozlu Hastaların Klinik ve Laboratuvar Özellikleri

Emekli A. S., GÜNDÜZ T., Samanci B., KÜRTÜNCÜ M.
Noropsikiyatri Arsivi , vol.62, no.2, pp.156-163, 2025 (SCI-Expanded) identifier identifier

2. Exome sequencing reveals low-frequency and rare variant contributions to multiple sclerosis susceptibility in Turkish families

Büyükgöl F., GÜRDAMAR B., Aluçlu M. U., Beckmann Y., BİLGÜVAR K., BOZ C., et al.
Scientific reports , vol.15, no.1, pp.11682, 2025 (SCI-Expanded) identifier identifier

3. Anti-JCV antibody index seroconversion in Turkish multiple sclerosis patients treated with natalizumab

Şahin E., GÜNDÜZ T., Emekli A. S., Ercanoğlu M., Erden S. Ö., KÜRTÜNCÜ M.
NEUROLOGICAL SCIENCES , vol.46, no.4, pp.1799-1805, 2025 (SCI-Expanded) Sustainable Development identifier identifier identifier

4. Retinoic acid modulates peripheral blood helper innate lymphoid cell composition in vitro in patients with multiple sclerosis

Özkoşar A., ÖKTELİK F. B., GELMEZ M. Y., Öztürk Erden S., GÜNDÜZ T., KÜRTÜNCÜ M., et al.
Journal of Neuroimmunology , vol.398, 2025 (SCI-Expanded, Scopus) identifier identifier

5. Experiences of people with multiple sclerosis using clean ıntermittent catheterization: a qualitative study

POLAT DÜNYA C., ÖZKAN İ., Yalçın G. Y., GÜNDÜZ T., KÜRTÜNCÜ M.
Disability and Rehabilitation , 2025 (SCI-Expanded, SSCI, Scopus) identifier identifier

6. Differentiating multiple sclerosis with predominant spinal cord and optic nerve involvement from other autoimmune demyelinating diseases using B cell immunophenotyping and gene expression profiling.

Yilmaz V., Karaaslan Z., Sanli E., Yuceer-Korkmaz H., Ulusoy C. A., Timirci-Kahraman Ö., et al.
Multiple sclerosis and related disorders , vol.93, pp.106238, 2025 (SCI-Expanded) identifier identifier identifier

7. Seronegative NMOSD patients display distinctive peripheral blood T-cell subset frequencies

Sanli E., Karaaslan Z., Yilmaz V., Gunduz T., Kurtuncu M., Turkoglu R., et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol.219, 2025 (SCI-Expanded) Sustainable Development identifier identifier identifier

8. Cerebral tumefactive demyelinating lesions: clinical spectrum, long-term outcomes, and treatment

Kizek Ö., Emekli A. S., GÜNDÜZ T., KÜRTÜNCÜ M., Eraksoy M.
Acta Neurologica Belgica , 2025 (SCI-Expanded) identifier identifier identifier

9. The agreement between face-to-face and tele-assessment of balance tests in patients with multiple sclerosis

Erekdag A., Sener I. N., ZENGİN ALPÖZGEN A., GÜNDÜZ T., Eraksoy M., KÜRTÜNCÜ M.
Multiple Sclerosis and Related Disorders , vol.90, 2024 (SCI-Expanded) identifier identifier identifier

10. Post-COVID-19 rhombencephalitis

KOÇ A., HUSEYNLI Z., GÜNDÜZ T., KÜRTÜNCÜ M.
Turkish Journal of Neurology , vol.30, no.3, pp.195-197, 2024 (Peer-Reviewed Journal) Sustainable Development

11. Neurological findings in patients with organic acidemias

Alıyeva G., Karakiraz A., Özdemir S., Durmuş A., Ak B., Kılıç Ş., et al.
European Journal of Neurology , vol.31, no.31, pp.12, 2024 (Conference Book)

12. Parenchymal Neuro-Behçet's disease or Comorbid Behçet's disease with multiple sclerosis: A discriminative analysis of a complex clinical entity

İsmayılov R., Talibov T., GÜNDÜZ T., KÜRTÜNCÜ M.
Multiple Sclerosis and Related Disorders , vol.87, 2024 (SCI-Expanded) identifier identifier

13. Diffusion Tensor Imaging in Parenchymal Neuro-Behçet's Disease

Gündüz T., Server S., Küçükali C. İ., Özyurt O., Akman-Demir G., Kürtüncü M.
NOROPSIKIYATRI ARSIVI , vol.61, no.1, pp.39-46, 2024 (SCI-Expanded)

14. Validity and Reliability of the Turkish Version of the Patient-Reported Impact of Spasticity Measure in Multiple Sclerosis

Yalçın G. Y., Dünya C. P., Yeni K., KÜRTÜNCÜ M., TÜLEK Z., GÜNDÜZ T., et al.
International Journal of MS Care , vol.26, no.Q3, pp.194-198, 2024 (Scopus) identifier identifier

15. Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement

KARAASLAN Z., Şengül-Yediel B., Yüceer-Korkmaz H., ŞANLI E., GEZEN AK D., DURSUN E., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.78, 2023 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

16. mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?

Tütüncü M., Demir S., Arslan G., Dinç Ö., Şen S., GÜNDÜZ T., et al.
Multiple Sclerosis and Related Disorders , vol.75, 2023 (SCI-Expanded) Sustainable Development identifier identifier

17. Evaluation of Demographic, Clinical Characteristics and Side Effects in Multiple Sclerosis Patients Vaccinated Against SARS-CoV-2 Virus

Kizek Ö., Yalçın G. Y., GÜNDÜZ T., Kürtüncü M., Eraksoy M.
TURKISH JOURNAL OF NEUROLOGY , vol.29, no.2, pp.106-110, 2023 (ESCI) Creative Commons License Sustainable Development identifier identifier identifier

18. Serum IgG of patients with relapsing inflammatory optic neuropathy immunoreacts with Sox2-positive glial cells of the optic nerve

Erdağ E., Emekli A. S., Gündüz T., Küçükali C. İ., Kürtüncü M., Tüzün E.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.73, 2023 (SCI-Expanded) Sustainable Development identifier identifier identifier

19. The Effect of Smoking on Inactivated and mRNA Vaccine Responses Applied to Prevent COVİD-19 in Multiple Sclerosis

Şen S., Arslan G., Tütüncü M., Demir S., Dinç Ö., GÜNDÜZ T., et al.
Noropsikiyatri Arsivi , vol.60, no.3, pp.252-256, 2023 (SCI-Expanded) Sustainable Development identifier identifier

20. Lesion probability map in cerebral vein thrombosis due to Behcet's disease

Emekli A. S., Dogan F. U., Gunduz T., Sezgin M., Ekizoglu E., Yesilot N., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.26, no.1, pp.145-150, 2023 (SCI-Expanded) Sustainable Development identifier identifier identifier

21. Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: case report

Inci M., GÜNDÜZ T., Kurtuncu M., Eraksoy M.
ACTA NEUROLOGICA BELGICA , vol.122, no.5, pp.1389-1391, 2022 (SCI-Expanded) identifier identifier identifier

22. The Socioeconomic and Psychological Impact of the COVID-19 Pandemic on People with Multiple Sclerosis in Turkey

Gunduz T., Uzunkopru C., Demir S., TÜTÜNCÜ M., Seferoglu M., GÜMÜŞ H., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.59, no.3, pp.226-231, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier identifier

23. Dimethyl Fumarate in Multiple Sclerosis Patients: A Real World Study

GÜNDÜZ T., ÖZTÜRK ERDEN S., ERAKSOY M., KÜRTÜNCÜ M.
Kocaeli Üniversitesi Sağlık Bilimleri Dergisi , vol.8, no.2, pp.129-133, 2022 (Peer-Reviewed Journal) identifier

24. Comparison of Mitoxantrone versus Cyclophosphamide Treatment in Patients with Secondary Progressive Multiple Sclerosis

GÜNDÜZ T., ÖZCAN G., ÇAKAR A., AKÇAY H. İ., ÖZDAĞ ACARLI A. N., ERAKSOY M., et al.
Dicle Tıp Dergisi , vol.49, no.1, pp.29-35, 2022 (Peer-Reviewed Journal) identifier

25. Lesion Distribution Pattern of Parenchymal Neuro-Behcet's Disease Using Probability Mapping

Emekli A. S., Ersozlu E., Emekli M. A., Gunduz T., Kurtuncu M.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

26. The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

Sen S., Tuncer A., ÖZAKBAŞ S., Uzunkopru C., Baba C., Demir S., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.58, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

27. CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients

KARAASLAN Z., KÜRTÜNCÜ M., Akcay H. I., GÜNDÜZ T., Altunrende B., Turkoglu R., et al.
EUROPEAN NEUROLOGY , vol.85, no.1, pp.69-71, 2022 (SCI-Expanded) identifier identifier identifier

28. Cerebrospinal fluid level of neurofilament light chain is associated with increased disease activity in neuro-Behcet's disease

Karaaslan Z., Şanlı E., Timirci-Kahraman Ö., Yılmaz V., Akbayır E., Koral G., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.4, pp.1266-1273, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

29. Coexistence of restless legs syndrome and multiple sclerosis aggravates anxiety and depression

Sevim S., DEMİRKIRAN D. M., TERZİ M., YÜCEYAR A. N., Tasdelen B., İDİMAN E., et al.
ARQUIVOS DE NEURO-PSIQUIATRIA , vol.80, pp.168-172, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

30. Clinical and Molecular Genetic Findings of Cerebral Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

Rustemoglu B. S., Samancı B., Tepgec F., Kürtüncü M., Altunoglu U., Gündüz T., et al.
TURKISH JOURNAL OF NEUROLOGY , vol.27, no.3, pp.240-247, 2021 (ESCI, Scopus, TRDizin) Creative Commons License Sustainable Development identifier identifier identifier

31. Detailed Evaluation of Macular Ganglion Cell Complex in Patients with Multiple Sclerosis

Özbilen K. T., Gündüz T., Kartal S. N. Ç., Aksu Ceylan N., Eraksoy M., Kürtüncü M.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.58, no.3, pp.176-183, 2021 (SCI-Expanded) identifier identifier identifier identifier

32. Evaluating the effects of transcutaneous tibial nerve stimulation or pelvic floor muscle training on sexual dysfunction in female multiple sclerosis patients reporting overactive bladder

POLAT DÜNYA C., TÜLEK Z., Kurtuncu M., Gunduz T., Panicker J. N., Eraksoy M.
NEUROUROLOGY AND URODYNAMICS , vol.40, no.6, pp.1661-1669, 2021 (SCI-Expanded) identifier identifier identifier

33. A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in Turkey

Demir S., TÜTÜNCÜ M., Uzunkopru C., GÜMÜŞ H., Seri S., Gunduz T., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.52, 2021 (SCI-Expanded) identifier identifier identifier

34. The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?

Sen S., Karabudak R., Schiavetti I., Demir S., Ozakbas S., Tutuncu M., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.52, 2021 (SCI-Expanded) Sustainable Development identifier identifier identifier

35. Bruch's membrane opening-minimum rim width: An alternative OCT biomarker study for multiple sclerosis

Ozbilen K. T., Gunduz T., Kartal S. N. C., Gedik A. C., Eraksoy M., Kurtuncu M.
EUROPEAN JOURNAL OF OPHTHALMOLOGY , vol.31, pp.2141-2149, 2021 (SCI-Expanded) identifier identifier identifier

36. The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey

Uzunkopru C., Tutuncu M., Gunduz T., GÜMÜŞ H., Sen S., Demir S., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.7, 2021 (SCI-Expanded) identifier identifier identifier

37. Clinical Features of the Patients with Neuromyelitis Optica Spectrum Disorder

Cakar A., Ulusoy C., Gunduz T., Kucukali C. I., Kurtuncu M.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.58, no.1, pp.21-25, 2021 (SCI-Expanded) identifier identifier identifier identifier

38. CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis.

Tamam Y., Gunes B., Akbayir E., Kizilay T., Karaaslan Z., Koral G., et al.
Multiple sclerosis and related disorders , vol.48, no.1, pp.102697, 2021 (SCI-Expanded) identifier identifier identifier

39. Adult-onset 4H leukodystrophy: a case presentation and review of the literature

Uygun O., Gunduz T., Eraksoy M., Kurtuncu M.
ACTA NEUROLOGICA BELGICA , vol.120, no.6, pp.1461-1462, 2020 (SCI-Expanded) identifier identifier identifier

40. Laboratory and clinical correlates of brain atrophy in Neuro-Behçet's disease

Gündüz T., Kürtüncü M., Matur Z., Tüzün E., Limon U., Tanyildiz B., et al.
Journal of the Neurological Sciences , vol.414, 2020 (SCI-Expanded) identifier identifier identifier

41. Coronavirus Disease 2019 (COVID-19) From the Point of View of Neurologists: Observation of Neurological Findings and Symptoms During the Combat Against a Pandemic

Özdağ A. N., Samanci B., Ekizoğlu E., Çakar A., Şirin N. G., Gündüz T., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.57, no.2, pp.154-159, 2020 (SCI-Expanded) Sustainable Development identifier identifier identifier

42. Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study

Ilki C. D., Gunduz T., Kurtuncu M., Yapici Z., Sencer S., Eraksoy M.
TURKISH JOURNAL OF NEUROLOGY , vol.26, no.1, pp.34-38, 2020 (ESCI) identifier identifier

43. Validation of the Turkish version of the eight-item actionable bladder symptom screening tool in multiple sclerosis

POLAT DÜNYA C., TÜLEK Z., Vizviz G. Y., Gunduz T., Panicker J. N., Kurtuncu M., et al.
NEUROUROLOGY AND URODYNAMICS , vol.39, no.1, pp.243-252, 2020 (SCI-Expanded) identifier identifier identifier

44. Impact of fingolimod on CD4+T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients

Kurtuncu M., Yilmaz V., Akcay H. I., Turkoglu R., Altunrende B., Cinar S., et al.
JOURNAL OF NEUROIMMUNOLOGY , vol.337, 2019 (SCI-Expanded) identifier identifier identifier

45. Psoriasiform eruption caused by teriflunomide in a patient with multiple sclerosis

Agirgol S., Kurtuncu M., Gurbuzel M., Tasyurek I., Gunduz T.
CLINICAL TOXICOLOGY , vol.57, no.11, pp.1125-1127, 2019 (SCI-Expanded) identifier identifier identifier

46. A Case of Leukoencephalopathy and Small Vessels Disease Caused by a Novel HTRA1 Homozygous Mutation

Gunduz T., Demirkol Y., Dogan O., Demir S., Akcakaya N. H.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES , vol.28, no.11, 2019 (SCI-Expanded) identifier identifier identifier

47. Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behcet's Disease

UGUREL E., ERDAG E., KUCUKALI C. İ., OLCAY A., Sanli E., AKBAYIR E., et al.
IN VIVO , vol.33, no.5, pp.1493-1497, 2019 (SCI-Expanded) identifier identifier identifier

48. Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid

Timirci-Kahraman O., Karaaslan Z., Tuzun E., Kurtuncu M., Baykal A. T., Gunduz T., et al.
ACTA NEUROLOGICA BELGICA , no.1, pp.101-111, 2019 (SCI-Expanded) identifier identifier identifier

49. Paraplegia following lumbar puncture: a rare complication in spinal dural arteriovenous fistula

Cakar A., Akcay H. I., Gunduz T., Kurtuncu M.
ACTA NEUROLOGICA BELGICA , vol.118, no.4, pp.543-545, 2018 (SCI-Expanded) identifier identifier identifier

50. Prognostic Factors in Anti-Neurona Antibody Positive Patients

Aydin C., Celik S. Y., Icoz S., Ulusoy C. A., Gunduz T., Akman Demir G., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.55, no.2, pp.189-194, 2018 (SCI-Expanded) identifier identifier identifier

51. Nasu-Hakola Disease.

Samanci B., Ulukan Ç., Gündüz T., Kürtüncü M., Eraksoy M.
Neurology India , vol.66, pp.263, 2018 (SCI-Expanded) identifier identifier

52. Analysis of distribution pattern using lesion probability mapping in parenchymal neuro-Behcet's disease

Emekli S., Ersozlu E., Gunduz T., Kurtuncu M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.36, no.6, 2018 (SCI-Expanded) identifier

53. Effect of smoking on disability progression in patients with multiple sclerosis

Gunduz T., Kurtuncu M.
TOBACCO INDUCED DISEASES , vol.16, pp.28, 2018 (SCI-Expanded) identifier

54. Cerebrospinal Fluid Analysis of Pericytic Mediators in Clinically Isolated Syndrome and Multiple Sclerosis: A Preliminary Study

GÜNDÜZ T., TANYEL KİREMİTÇİ T., ULUSOY C. A., KÜRTÜNCÜ M., TÜRKOĞLU R.
Experimed , vol.81, no.1, pp.18-22, 2018 (Peer-Reviewed Journal)

55. Neurobrucellosis presenting with mania

Akcay H. I., Kurtuncu M., Celik S. Y., Gunduz T., Eraksoy M.
ACTA NEUROLOGICA BELGICA , vol.117, no.1, pp.373-375, 2017 (SCI-Expanded) identifier identifier identifier

56. Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis

Gunduz T., Kurtuncu M., Eraksoy M.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.11, pp.1-3, 2017 (SCI-Expanded) identifier identifier identifier

57. Characteristics of isolated spinal cord involvement in neurobrucellosis with no corresponding MRI activity: A case report and review of the literature

Gunduz T., Tekturk P., Yapici Z., Kurtuncu M., Somer A., Torun S., et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES , pp.305-306, 2017 (SCI-Expanded) Sustainable Development identifier identifier identifier

58. Does Serum Vitamin D Level During Pregnancy Influence the Risk of Multiple Sclerosis?

Gunduz T.
TURKISH JOURNAL OF NEUROLOGY , vol.22, no.4, pp.203, 2016 (ESCI) identifier

59. Effect of Early Treatment of Hypertension in Acute Cerebral Hemorrhage: New Evidences

Gunduz T.
TURKISH JOURNAL OF NEUROLOGY , vol.22, no.4, pp.204, 2016 (ESCI) identifier

60. Effect of Thymectomy in Myasthenia Gravis

Gunduz T.
TURKISH JOURNAL OF NEUROLOGY , vol.22, no.4, pp.202, 2016 (ESCI) identifier identifier

61. Is Very Early Mobilization after Stroke Effective?

Gunduz T., Akcay H. I., Kurtuncu M.
TURKISH JOURNAL OF NEUROLOGY , vol.21, no.4, pp.179, 2015 (ESCI) identifier

62. Frontiers in neurology Nörolojide Öne Çıkanlar

GÜNDÜZ T., Akçay H. İ., KÜRTÜNCÜ M.
Turk Noroloji Dergisi , vol.21, no.4, pp.179-181, 2015 (Scopus) identifier

63. Does Central Nervous System have a Lymphatic Circulation?

Gunduz T., Akcay H. I., Kurtuncu M.
TURKISH JOURNAL OF NEUROLOGY , vol.21, no.4, pp.179-180, 2015 (ESCI) identifier

64. Orolingual Dyskinesia and Involuntary Neck Movements Caused by Phenytoin Intoxication

Gunduz T., Kocasoy-Orhan E., Hanagasi H. A.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES , vol.25, no.4, 2013 (SCI-Expanded) identifier identifier identifier

65. Cognitive Impairment in Neuro-Behcet's Disease and Multiple Sclerosis: A Comparative Study

Gunduz T., Emir O., Kurtuncu M., Mutlu M., Tumac A., Akca S., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE , no.11, pp.650-656, 2012 (SCI-Expanded) identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 80

1. The effect of sexual counselling with the PLISSIT model on sexual function and sexual quality of life in women with multiple sclerosis: a randomized controlled trial

POLAT DÜNYA C., TUNCER M., ÖZKAN İ., YALÇIN G. Y., GÜNDÜZ T., KÜRTÜNCÜ M.
ECTRIMS 2025, Barselona, Spain, 24 - 26 September 2025, (Summary Text)

2. Alternate-Day Fingolimod Tapering: Impact on Rebound Disease Activity in Patients with Multiple Sclerosis

Gündüz T., İşkan N. G., Sevimli A., Büke B., Emekli A. S., Kürtüncü M.
The 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Kobenhavn, Denmark, 18 September 2024, vol.30, pp.4-124, (Summary Text)

3. Alternate-Day Fingolimod Tapering: Impact on Rebound Disease Activity in Patients with Multiple Sclerosis

GÜNDÜZ T., İŞKAN N. G., Sevimli A., BÜKE B., Emekli A. S., KÜRTÜNCÜ M.
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Denmark, 18 - 20 September 2024, pp.107, (Summary Text) identifier

4. Aquaporin-1 antibodies in autoimmune inflammatory demyelinating disorders with predominant optic nerve & spinal cord involvement

TÜZÜN E., Kaptov E., YILMAZ V., Pechlivanidou M., KÜRTÜNCÜ M., GÜNDÜZ T., et al.
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Denmark, 18 - 20 September 2024, vol.30, pp.885, (Summary Text) identifier

5. Otoimmün Demiyelizan Hastalıkların Ayırıcı Tanısında CCL4L2’nin B Hücre Temelli Biyobelirteç Olarak Değeri

Koral G., Akpunar F., Şanlı E., Karaaslan Z., Yüceer H., Özkan E., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Turkey, 13 - 18 December 2023, pp.89, (Summary Text) Sustainable Development

6. Possible Diagnostic Biomarkers in The Differential Diagnosis of Autoimmune Demyelinating Central Nervous System Diseases: Sorcin and CLIC1

Karaaslan Z., Şengül Yediel B., Şanlı E., Yüceer H., Dursun E., Gezen Ak D., et al.
9th Joint ECTRIMS-ACTRIMS Meeting, Milan, Italy, 11 - 13 October 2023, vol.29, no.3, pp.574-575, (Summary Text)

7. Parenchymal Neuro-Behçet’s Disease or Comorbid Behçet’s Disease with Multiple Sclerosis: A Discriminative Analysis of a Complex Clinical Entity

ISMAYILOV R., GÜNDÜZ T., TALİBOV T., KÜRTÜNCÜ M.
MSMilan2023 9th ECTRIMS-ACTRIMS Meeting, Milan, Italy, 11 October 2023, vol.29, pp.137-393, (Summary Text)

8. Comparative Analysis of Diagnostic Criteria for Radiologically Isolated Syndrome (S31.009)

GÜNDÜZ T., ÇİFTÇİ GEDİK İ., PİRİ ÇİNAR B., BABA C., SEFEROĞLU M., SIVACI A. Ö., et al.
75th American Academy of Neurology Annual Meeting, BOSTON, United States Of America, 22 - 27 April 2023, vol.100, (Summary Text) identifier

9. Multipl Skleroz Hastalarında Beyin Omurilik Sıvısı Nörofilament Hafif Zincir Seviyesinin Prognostik Değeri

Demirel A., Şahin E., Gündüz T., Yılmaz V., Tüzün E., Öztürk Erden S., et al.
58. Ulusal Nöroloji Kongresi, Antalya, Turkey, 19 - 24 November 2022, pp.63, (Summary Text)

10. Ataklarla Seyreden Multipl Skleroz Hastalarında Grup 2 Doğal Lenfoid Hücre Plastisitesi Üzerine Retinoik Asitin Etkisi.

Özkoşar A., Öktelik F. B., Gelmez M. Y., Eren S. Ö., Gündüz T., Kürtüncü M., et al.
58. Ulusal Nöroloji Kongresi (Uluslararası Katılımlı), Antalya, Turkey, 19 - 24 November 2022, pp.1, (Summary Text)

11. Otoimmün demiyelinizan santral sinir sistemi hastalıkları ayırıcı tanısında olası biyobelirteçler: Sorcin, CLIC1 ve Src substrate cortactin

Karaaslan Z., Şengül Yediel B., Şanlı E., Yüceer H., Dursun E., Gezen Ak D., et al.
58. Ulusal Nöroloji Kongresi, Antalya, Turkey, 18 - 24 November 2022, pp.200, (Summary Text)

12. B cell gene expression profile in different demyelinating diseases

Karaaslan Z., Şanlı E., Yüceer H., Timirci Kahraman Ö., Gündüz T., Kürtüncü M., et al.
International Molecular Immunology & Immunogenetics Congress V (MIMIC V), İzmir, Turkey, 20 - 22 October 2022, (Summary Text)

13. Impact of Retinoic Acid on Group 2 Innate Lymphoid Cell Plasticity in Patients with Relapsing-Remitting Multiple Sclerosis.

Özkoşar A., Öktelik F. B., Gelmez M. Y., Erden Öztürk S., Gündüz T., Kurtuncu M., et al.
5th International Molecular Immunology & Immunogenetics Congress (MIMIC-V), İzmir, Turkey, 20 - 22 October 2022, pp.1, (Summary Text)

14. Paraplegia following lumbar puncture: a rare complication of spinal dural arteriovenous fistula

ÇAKAR A., AKÇAY H. İ., GÜNDÜZ T., KÜRTÜNCÜ M.
2nd Congress of European Academy of Neurology, Kopenhag, Denmark, 28 - 31 May 2016, (Summary Text)

15. Cladribine treatment in turkish MS patients

Gunduz T., Koseoglu M., Ozen P. A., Tutuncu M., Uzunkopru C., Demir S., et al.
38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 26 - 28 October 2022, pp.889-890, (Summary Text) identifier

16. Multipl Skleroz Hastalarında Dimetil Fumarat: Bir Gerçek Yaşam Çalışması

GÜNDÜZ T., Öztürk Erden S., ERAKSOY M., KÜRTÜNCÜ M.
57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Summary Text)

17. Periferik Kan İmmünfenotiplemesi OSMS'yi NMOSH'den Ayırabilir mi?

KARAASLAN Z., ŞANLI E., YÜCEER H., ULUSOY C. A., KÜÇÜKALİ C. İ., TİMİRCİ KAHRAMAN Ö., et al.
57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Summary Text)

18. İzole Merkezi Sinir Sistemi IgG4 ilişkili Hastalık Tanısında Yeni bir Belirteç: Beyin Omurilik Sıvısı IgG4 İndeksi

BUĞDAYCI Z. G., KİZEK Ö., GÜNDÜZ T., ERAKSOY M., KÜRTÜNCÜ M.
57. Ulusal Nöroloji Kongres, Antalya, Turkey, 27 November - 01 December 2021, (Summary Text)

19. Parenkimal Nöro-Behçet Hastalığında Difüzyon Tensor Görüntüleme Bulguları

GÜNDÜZ T., SERVER S., KÜÇÜKALİ C. İ., ÖZYURT O., DEMİR F. G., KÜRTÜNCÜ M.
57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Summary Text)

20. Çocuklarda Bilişsel Ölçüm Yetişkinlerden Farklı mı? 

GÜNDÜZ T.
6. Multipl Sklerozda Kognisyon Sempozyumu, İzmir, Turkey, 13 - 14 November 2021, (Summary Text)

21. Can OSMS be differentiated from NMOSD and MS by peripheral blood immunophenotyping?

Şanlı E., Karaaslan Z., Yüceer H., Ulusoy C. A., Küçükali C. İ., Timirci Kahraman Ö., et al.
15th International Society of Neuroimmunology (ISNI) Congress, Nice, France, 8 - 12 November 2021, (Unpublished)

22. Covid-19 Aşısı Sonrası Gelişen Optik Nöropati Olgusu

Karadağ B., Aksu Ceylan N., Gündüz T.
TOD 55.Ulusal Kongresi, Antalya, Turkey, 03 November 2021, pp.131, (Summary Text)

23. “Ağır” Engellilik: Yatağa Bağımlı Olmak Nedenleri

GÜNDÜZ T.
5. Multipl Sklerozda Fiziksel Engellilik Sempozyumu, İzmir, Turkey, 22 - 23 May 2021, (Summary Text)

24. Multipl Sklerozda Biyobelirteç Olarak Bruch Membran Açıklığı-Minimum Rim Genişliği’nin Değerlendirilmesi

ÖZBİLEN K. T., GÜNDÜZ T., ÇUKUROVA S. N., GEDİK A. C., ERAKSOY M., KÜRTÜNCÜ M.
56. Ulusal Nöroloji Kongresi, Turkey, 28 November - 02 December 2020, (Summary Text) Sustainable Development

25. Bilişsel Tutulumda Progresyon – Biyolojik Belirteç İlişkisi

GÜNDÜZ T.
5. Multipl Sklerozda Kognisyon Sempozyumu, Turkey, 6 - 07 November 2020, (Summary Text)

26. NFL Fiziksel Engellilikte Prognostik Etmen Olabilir mi?

GÜNDÜZ T.
4. Multipl Sklerozda Fiziksel Engellilik Sempozyumu, Turkey, 6 - 07 November 2020, (Summary Text)

27. AN OPEN-LABEL, EXPLORATORY STUDY TO ESTABLISH THE EFFICACY AND SAFETY OF 1-YEAR CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT

GÜL A., KÜRTÜNCÜ M., Erdugan M., OĞUZ E., GÜNDÜZ T., DEMİR G., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 June 2020, vol.79, pp.1533-1534, (Summary Text) Creative Commons License identifier

28. Natural Course of Relapsing Tumefactive Multiple Sclerosis and Tumefactive Demyelinating Lesions

Kizek O., Dogan F. U., Gunduz T., Kurtuncu M., Eraksoy M.
Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text) identifier

29. Analysis of Lesion Localization Pattern of Patients with Parenchymal Neuro-Behcet's Disease Using Probability Mapping

Emekli A., Ersozlu E., Gunduz T., Kurtuncu M.
Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text) identifier

30. Progressive Multifocal Leukoencephalopathy Associated with Idiopathic CD4+Lymphocytopenia in a Patient with Heterozygous STAT4 Mutation

Acarli A. N. O., Tuzer C., Gunduz T., Ismayilov R., PARILTAY E., Alpman A., et al.
Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text) identifier

31. Cortical Laminar Necrosis Following the Rapid Correction of Hyponatremia-A Case Report

Tasdemir V., Gunduz T., Kurtuncu M.
Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text) identifier

32. Recurrent Intracerebral Hemorrhage Due to Alemtuzumab Treatment in a Patient with Multiple Sclerosis: Case Report

Inci M., Gunduz T., Kurtuncu M., Eraksoy M.
Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text) identifier

33. Parenkimal NöroBehçet Hastalığında Lezyon Dağılım Paterninin Olasılık Haritalaması Kullanarak Analizi

EMEKLİ A. S., ERSÖZLÜ E., GÜNDÜZ T., KÜRTÜNCÜ M.
55. Ulusal Nöroloji Kongresi 15 Kasım – 21 Kasım 2019, Antalya, Antalya, Turkey, 15 - 21 November 2019, (Summary Text)

34. Doz Azaltarak Kesme Stratejisi Fingolimod Sonrası Rebound Aktivitesini Engeller mi?

GÜNDÜZ T., ISMAYILOV R., KÜRTÜNCÜ M.
55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 15 - 21 November 2019, (Summary Text)

35. İstanbul Tıp Fakültesi’nin Alemtuzumab Gerçek Yaşam Verisi

AYDOĞAN A., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.
55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 15 November - 21 September 2019, (Summary Text)

36. The Survival of Turkish Patients with Multiple Sclerosis

ŞAMLI S., ŞAHBAZ T., GÜNDÜZ T., UYANIK İ., KÜRTÜNCÜ M.
35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Stockholm, Sweden, 11 - 13 September 2019, vol.25, pp.3-130, (Summary Text)

37. The survival of patients with multiple sclerosis in Turkey

Samli S., Sahbaz T., Gunduz T., Uyanik I., Kurtuncu M.
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 11 - 13 September 2019, pp.47, (Summary Text) identifier

38. Rebound disease activity after cessation of fingolimod treatment

Gunduz T., Ismailov R., Kurtuncu M.
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 11 - 13 September 2019, vol.25, pp.552, (Summary Text) identifier

39. Comparison of headache characteristics in patients with neuromyelitis optica spectrum disorder and multiple sclerosis

UYGUN Ö., GÜNDÜZ T., KÜRTÜNCÜ M., BAYKAL B.
5th Congress of the European Academy of Neurology, Oslo, Norway, 29 June - 02 July 2019, (Summary Text)

40. Spastisitenin ölçümü

GÜNDÜZ T.
3. Multipl Sklerozda Fiziksel Engelliliğin Ölçümü Sempozyumu, İzmir, Turkey, 18 - 19 May 2019, (Summary Text)

41. Long-Term Follow-Up and Results of Patients with MRI Negative Demyelinating Diseases

Kizek O., Ilki C. D., Gunduz T., Kurtuncu M., Eraksoy M.
71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text) identifier

42. TERİFLUNOMİD TEDAVİSİNİN MULTİPL SKLEROZ İLE İLİŞKİLİ ÜVEİT ÜZERİNE ETKİSİ

GÜNDÜZ T., AKSU CEYLAN N., ORAY M., TUTKUN N. İ., KÜRTÜNCÜ M.
NÖRO-OFTALMOLOJİ NÖRO-OTOLOJİ SEMPOZYUMU, Turkey, 22 - 24 March 2019

43. Teriflunomid Tedavisinin Multipl Skleroz ile İlişkili Üveit Üzerine Etkisi

GÜNDÜZ T., AKSU CEYLAN N., ORAY M., TUGAL TUTKUN İ., KÜRTÜNCÜ M.
Nöro-oftalmoloji – Nöro-otoloji sempozyumu 2019, İstanbul, Turkey, 22 - 24 March 2019, (Summary Text)

44. Plasebo Kontrollü Randomize Multipl Skleroz Çalışmalarında Ortalamaya Dönüş Hatası Yıllar İçinde Artmaktadır

EMEKLİ A. S., ERSÖZLÜ E., GÜNDÜZ T., KÜRTÜNCÜ M.
54. Ulusal Nöroloji kongresi, Turkey, 30 November - 06 December 2018, (Summary Text)

45. Behçet Hastalığı Zemininde Ortaya Çıkan Kronik İnflamatuar Demiyelinizan Polinöropati Olgusu

DOĞAN F. U., GÜNDÜZ T., PARMAN F. Y., ERAKSOY M., KÜRTÜNCÜ M.
54. Ulusal Nöroloji kongresi, Turkey, 30 November 2018, (Summary Text)

46. Radyolojik İzole Sendromlu Hastaların Multipl Skleroza Dönüşümünü Öngören Faktörler

ÇİFTÇİ İ., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.
54. Ulusal Nöroloji Kongresi, Antalya, Turkey, 30 November - 06 December 2018, (Summary Text)

47. Nöro-behçet Hastalığı Ne Kadar Süre Tedavi Edilmeli?

GÜNDÜZ T., AYDIN B. N., ALA SELEK S., DEMİR F. G., KÜRTÜNCÜ M.
54. Ulusal Nöroloji Kongresi, Turkey, 30 November - 06 December 2018, (Summary Text)

48. Çocukluk Yaş Başlangıçlı Demiyelinizan Hastalıklarda Klinik-demografik Özellikler Ve Anti-MOG (Myelin Oligodendrosit Glikoprotein) Antikorlarının Prognoz Üzerindeki Etkilerinin Belirlenmesi

DUMAN İLKİ C., GÜNDÜZ T., TOPALOĞLU P., YAPICI Z., KÜRTÜNCÜ M., ERAKSOY M.
54. Ulusal Nöroloji Kongresi, Turkey, 30 November - 06 December 2018, (Summary Text)

49. Predictors for conversion of radiologically isolated syndrome to multiple sclerosis

Ciftci I., Gunduz T., Kurtuncu M., Eraksoy M.
34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Germany, 10 - 12 October 2018, pp.760-761, (Summary Text) identifier

50. Is placebo effect getting bigger in randomized controlled trials of multiple sclerosis?

Emekli A. S., Ersozlu E., Kurtuncu M., Gunduz T., Eraksoy M.
34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Germany, 10 - 12 October 2018, pp.971-972, (Summary Text) identifier

51. Relatıon Between Edss Bladder Functıonal System Score And Clınıcal Features In Multıple Sclerosıs

POLAT DÜNYA C., KÜRTÜNCÜ M., TÜLEK Z., GÜNDÜZ T., ERAKSOY M.
4th Congress of the European Academy of Neurology, Lisbon, Portugal, 16 - 19 June 2018, pp.1, (Full Text)

52. Long-term follow-up of patients with Neuro-Behcet's disease

Kurtuncu M., Gunduz T., Aydin B. N., Emekli A. S., Demir G. A.
4th Congress of the European-Academy-of-Neurology (EAN), Lisbon, Portugal, 16 - 19 June 2018, pp.355, (Summary Text) identifier

53. A Patient with 4H Syndrome Who Presents in Adulthood

Uygun O., Gunduz T., Kurtuncu M., Eraksoy M.
70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text) identifier

54. Multipl sklerozda EDSS- Mesane fonksiyonel durumunun klinik özellikler ile ilişkisi: Retrospektif Çalışma

POLAT C., KÜRTÜNCÜ M., TÜLEK Z., GÜNDÜZ T., ERAKSOY M.
Multiple Skleroz Hemşire Sempozyumu, Gaziantep, Turkey, 24 - 25 March 2018, pp.1, (Full Text)

55. KALITIMSAL NÖROLOJİK HASTALIKLARIN TANISINDA NE KADAR İLERİ GİDİLMELİ? BİR CARASIL AİLESİNİN ANALİZİ

Şahin İ., Sezgin M., Gündüz T., Kürtüncü M.
53. Ulusal Nöroloji Kongresi, Antalya, Turkey, 24 - 30 November 2017, pp.243, (Summary Text)

56. Multipl skleroz gelişiminde aday biyomarkerlarin proteomiks analiz yöntemi ile belirlenmesi

TİMİRCİ KAHRAMAN Ö., KARAASLAN Z., KÜÇÜKALİ C. İ., TÜZÜN E., BAYKAL A. T., KÜRTÜNCÜ M., et al.
53. ulusal nöroloji kongres, Turkey, 24 - 30 November 2017, (Summary Text)

57. Genetic polymorphism of aquaporin-4 gene in neuromyelitis optica spectrum disorder

Cakar A., Akcay H. I., Ulusoy C., Kucukali C. I., Tuzun E., Gunduz T., et al.
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 25 - 28 October 2017, pp.692-693, (Summary Text) identifier

58. Neuro-behcet's disease: Analysis of 430 patients

Kurtuncu M., Aydin B. N., Gunduz T., Ala S., Akman-Demir G.
23rd World Congress of Neurology (WCN), Kyoto, Japan, 16 - 21 September 2017, pp.121-122, (Summary Text) identifier

59. Comorbid autoimmunity is not a prognostic factor in multiple sclerosis

Gunduz T., Emekli A. S., Kurtuncu M., Eraksoy M.
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 25 - 28 October 2017, pp.486, (Summary Text) identifier

60. HoxB3, a novel biomarker that predicts conversion to multiple sclerosis

Tuzun E., Karaaslan Z., Timirci-Kahraman O., Ulusoy C., Kucukali C. I., Gunduz T., et al.
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 25 - 28 October 2017, pp.428-429, (Summary Text) identifier

61. Pseudotumor Cerebri Related to Behçet's disease

İBRAHİMOVA G., GÜNDÜZ T., DEMİR F. G., KÜRTÜNCÜ M.
3rd Congress of the European Academy of Neurology, Amsterdam, Netherlands, 24 - 27 June 2017, (Summary Text)

62. Disability Progression in Multiple Sclerosis is Biphasic with Uniform Trajectory after Expanded Disability Status Score of Three

UYANIK İ., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.
3rd Congress of the European Academy of Neurology, Amsterdam, Netherlands, 24 - 27 June 2017, (Summary Text)

63. Pseudotumor cerebri related to Behcet's disease

Ibrahimova G., Gunduz T., Demir G. A., Kurtuncu M.
3rd Congress of the European-Academy-of-Neurology, Amsterdam, Netherlands, 01 June 2017, pp.283, (Summary Text) identifier

64. Multipl Skleroza Dönüşümü Tahmin Eden Yeni Bir Biyobelirteç: HOXB3

Karaaslan Z., Timirci-Kahraman Ö., Ulusoy C., KÜÇÜKALİ C. İ., Tüzün E., Gündüz T., et al.
52. Ulusal Nöroloji Kongresi, Antalya, Turkey, 25 November - 01 December 2016, (Full Text)

65. Fingolimod Tedavisinin Multipl Skleroz hastalarında periferik kan hücre immünofenotipleri üzerine etkisi

AKÇAY H. İ., ULUSOY C. A., ÇINAR S., YILMAZ V., Türkoğlu R., Altunrende B., et al.
52. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Turkey, 25 November - 01 December 2016, pp.30, (Full Text)

66. Nöromiyelitis Optika Hastalarında Aquaporin-4 Gen Polimorfizmi

Cakar A., Ulusoy C., KÜÇÜKALİ C. İ., Tüzün E., Gündüz T., Kürtüncü M., et al.
52. Ulusal Nöroloji Kongresi, Antalya, Turkey, 25 November - 01 December 2016, (Full Text)

67. Fingolimod Tedavisinin Multipl Skleroz Hastalarında Periferik Kan hücre İmmunufenotipleri üzerine Etkisi

AKÇAY H. İ., ULUSOY C. A., ÇINAR S., YILMAZ V., TÜRKOĞLU R., ALTUNRENDE B., et al.
52. Ulusal Nöroloji Kongresi, Turkey, 25 November - 01 December 2016, (Summary Text)

68. Multipl Skleroz Hastalarının Doğum Ayı İle Cinsiyet Arasında Bir İlişki Var mı?

UYANIK İ., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.
52. Ulusal Nöroloji Kongresi, Tartışmalı E-poster - 121, Turkey, 25 November - 01 December 2016, (Summary Text)

69. Worsening of trigeminal neuralgia by dalfampridine in patients with multiple sclerosis

Kurtuncu M., Gunduz T., Oztorun F., Ala S., Eraksoy M.
32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Canada, 14 - 17 September 2016, pp.814-815, (Summary Text) identifier

70. Aseptic Meningitis As A Rare Manifestation of Neuro-Behçet’s Disease: Long Term Follow-up of Six Patients

ÖZDAĞ ACARLI A. N., GÜNDÜZ T., ALA SELEK S., DEMİR F. G., KÜRTÜNCÜ M.
2nd Congress of European Academy of Neurology, Kopenhag, Denmark, 28 - 31 May 2016, (Summary Text)

71. Comparison of Mitoxantrone versus Cyclophosphamide in Patients with Secondary Progressive Multiple Sclerosis

GÜNDÜZ T., ÖZCAN G., ÇAKAR A., AKÇAY H. İ., ÖZDAĞ ACARLI A. N., KÜRTÜNCÜ M., et al.
2nd Congress of European Academy of Neurology, Kopenhag, Denmark, 28 - 31 May 2016, vol.23, pp.601-879, (Summary Text)

72. Adrenokorti̇kal yetersi̇zli̇kte ön planda akla gelmeyen di̇ğer etyoloji̇ler.

HACİŞAHİNOĞULLARI H., KOÇ M. S., MASTANZADE M., KUBAT ÜZÜM A., GÜNDÜZ T., KARACA M., et al.
38. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Turkey, 11 May 2016, (Summary Text)

73. The effect of fingolimod treatment on peripheral blood cell immunophenotypes in patients with multiple sclerosis

ULUSOY C. A., ÇINAR S., YILMAZ V., AKÇAY H. İ., Türkoğlu R., GÜNDÜZ T., et al.
International Molecular Immunology & Immunogenetcs Congress (MIMIC-III), Antalya, Turkey, 27 - 30 April 2016, vol.4, pp.75, (Full Text)

74. Withdrawal Rebound after Fingolimod in Multiple Sclerosis Patients

Gunduz T., Kurtuncu M., Eraksoy M.
68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Canada, 15 - 21 April 2016, vol.86, (Summary Text) identifier

75. Switching From Glatiramer Acetate: Comparison of Disease Modifying Treatments

Kurtuncu M., Akcay H. I., Cakar A., Gunduz T., Tuzun E., Eraksoy M.
ACTRIMS Forum, Louisiana, United States Of America, 18 - 20 February 2016, vol.22, pp.18-19, (Summary Text) identifier

76. Clinical and genetic features of the patients with MNGIE: cohort at the department of neurology, Istanbul Faculty of Medicine

Cakar A., Durmus H., Gunduz T., Deymeer F., Parman Y., Oflazer-Serdaroglu P.
Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.261, (Summary Text) identifier

77. Clinical and genetic features of patients with MNGIE: cohort at the department of neurology, Istanbul Faculty of Medicine

Cakar A., Durmus H., Gunduz T., Deymeer F., Parman Y., Oflazer-Serdaroglu P.
Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.21, pp.519, (Summary Text) identifier

78. A Case Of MRI Negative Neurobrucellosis With Isolated Spinal Cord Involvement

GÜNDÜZ T., TOPALOĞLU P., ERAKSOY M., YAPICI Z.
ICNC2012 (12th International Child Neurology Congress), Brisbane, Australia, 27 May - 01 June 2012, vol.54, pp.1-220, (Summary Text)

79. Familial effects on the age of onset, initial symptoms and clinical course of multiple sclerosis

ERAKSOY M., DEMİR F. G., YAPICI Z., GÜNDÜZ T., KÜRTÜNCÜ M.
20th Meeting of the European Neurological Society, Berlin, Germany, 19 - 23 June 2010, vol.257, pp.1-246, (Summary Text)

80. Familial effects on the age of onset, initial symptoms and clinical courses of multiple sclerosis

Eraksoy M., Akman-Demir G., Yapici Z., Gunduz T., Kurtuncu M.
20th Meeting of the European-Neurological-Society, Berlin, Germany, 19 - 23 June 2010, (Summary Text) identifier
Books 8

1. Merkezi Sinir Sisteminin Bariyerleri

GÜNDÜZ T.
in: Nöroimmünoloji, Yücesan Canan, Tuncer Aslı, Uzunköprü Cihat, Editor, Nobel Tıp Kitabevleri, İstanbul, pp.21-28, 2023

2. Akut Hemorajik Lökoensefalit

GÜNDÜZ T.
in: Nöroimmünoloji, Yücesan Canan, Tuncer Aslı, Uzunköprü Cihat, Editor, Nobel Tıp Kitabevleri, İstanbul, pp.233-237, 2023

3. Tele-Nöroloji

BAŞAR GÜRSOY A. E., GÜNDÜZ T.
in: Tele Sağlık, Soysal Pınar, Tükek Tufan, Editor, İSTANBUL TIP KİTABEVLERİ, İstanbul, pp.308-327, 2022

4. Multipl Skleroz Tedavilerine İkincil Otoimmün Komplikasyonlar

GÜNDÜZ T.
in: Multipl Skleroz Tedavisinde Kullanılan İlaçların İzlem ve Güvenlik Kılavuzu, Bilge Piri Çinar, Aslı Tuncer, Hüsnü Efendi, Aksel Siva, Editor, Bayçınar Tıbbi Yayıncılık, Ankara, pp.99-106, 2022

5. Neuropsychiatric Symptoms in Neuro-Behçet’s Disease

GÜNDÜZ T., ERTEKİN E.
in: Neuro-Behçet’s Disease, TÜZÜN ERDEM, KÜRTÜNCÜ MURAT, Editor, Springer, Cham, New York, pp.107-121, 2021

6. Merkezi Sinir Sisteminin Diğer Otoimmün ve İnflamatuar Demyelinizan Hastalıkları

GÜNDÜZ T., DEMİR F. G.
in: Nöroloji, ÖGE ALİ EMRE, BAYKAL BETÜL, BİLGİÇ BAŞAR, Editor, NOBEL TIP KİTABEVİ, İstanbul, pp.797-819, 2021

7. Multipl Skleroz Ayırıcı Tanısı

UZUNKÖPRÜ C., GÜNDÜZ T.
in: Multipl Skleroz, Beckmann Yeşim, Uzunköprü Cihat, Editor, EMA Tıp Kitabevi ve Yayıncılık, İstanbul, pp.357-412, 2021

8. MULTİPL SKLEROZDA MONOKLONAL ANTİKORLAR

GÜNDÜZ T., YÜKSEL B., TAMAM Y., İRKEÇ C., KARABUDAK R.
in: Multipl Skleroz tanı ve tedavi kılavuzu 2018, Hüsnü Efendi, Demet Yandım Kuşçu, Editor, Galenos Yayınevi, İstanbul, pp.86-108, 2018
Other Publications 1

1. Multipl Skleroz Gelişiminde Aday Biyomarkerların Proteomiks Analiz Yöntemi ile Belirlenmesi

TİMİRCİ KAHRAMAN Ö., KÜÇÜKALİ C. İ., KARAASLAN Z., TÜZÜN E., BAYKAL A. T., KÜRTÜNCÜ M., et al.
Presentation, pp.1-2, 2017
Metrics

Publication

154

Publication (WoS)

86

Publication (Scopus)

60

Citation (WoS)

257

H-Index (WoS)

9

Citation (Scopus)

271

H-Index (Scopus)

9

Citation (Scholar)

302

H-Index (Scholar)

9

Citation (TrDizin)

4

H-Index (TrDizin)

1

Project

5

Open Access

6
UN Sustainable Development Goals